[Objectives]To establish an High Performance Liquid Chromatography(HPLC)method for simultaneous determination of four amino acids in Fufang Ejiao Buxue Granule.[Methods]The quantitative analysis was carried out with a...[Objectives]To establish an High Performance Liquid Chromatography(HPLC)method for simultaneous determination of four amino acids in Fufang Ejiao Buxue Granule.[Methods]The quantitative analysis was carried out with a Waters Sunfire C 18 column(4.6 mm×250 mm,5μm).A binary mobile solvent was used:mobile solvent A was acetonitrile-0.1 mol/L sodium acetate solution(adjusting pH to 6.5 with 36%acetic acid)(7∶93)and mobile solvent B was acetonitrile-H 2O(4∶1).The mobile phase was delivered at a flow rate of 1.0 mL/min with a gradient elution profile(0-13 min,100%A→93%A;13-17.9 min,93%A→88%A;17.9-29.0 min,88%A→85%A;29-39 min,85%A→66%A;39-45 min,66%A→0%A).The column temperature was at 43℃.The detection wavelength was 254 nm.[Results]The injection volume of L-hydroxyproline,glycine,alanine,and L-proline showed a good linear relationship with the chromatographic peak area in the range of 0.012 to 0.117,0.022 to 0.218,0.010 to 0.097,0.016 to 0.160μg,separately.The average recovery rate(n=6)was 96.4%,97.3%,97.1%,and 99.4%,respectively;the relative standard deviations were 1.2%,1.9%,1.7%,and 0.9%,respectively.[Conclusions]This method is simple in operation and good in reproducibility,and provides a reliable method for controlling the quality of Fufang Ejiao Buxue Granules.展开更多
Objective To explore the transitive regularity of holistic constituents from the crude slices of the medicinal raw materials(MCS)to the formula granules(FG),fufang decoction(FD),and finally,the concentrated pills(CP)o...Objective To explore the transitive regularity of holistic constituents from the crude slices of the medicinal raw materials(MCS)to the formula granules(FG),fufang decoction(FD),and finally,the concentrated pills(CP)of Liuwei Dihuang Fufang(六味地黄复方,LWDHF).Methods Samples for MCS,FG,FD,and CP of LWDHF were obtained,and a fingerprint data-base was established using high-performance liquid chromatography(HPLC),by separating the samples in an XB-C18 column and analyzing the transitive regularity of components us-ing the total quantum statistical moment(TQSM),including total quantum zero moment(AUCT),total quantum first moment(MRTT),total quantum second moment(VRTT),and its similarity approach.The AUCT,MRTT,and VRTT were calculated based on the representative HPLC chromatograms of FG,FD,and CP of LWDHF.Results AUCT of FG,FD,and CP of LWDHF was 71804,46553,and 144646μV·s,respectively;MRTT was 14.43,14.54,and 18.85 min,respectively;and VRTT was 106.98,112.84,and 269.12 min2,respectively.Comparing the similarity of FG/FD,FG/CP and FD/CP of LWDHF,the TQSM similarity values were 98.66%,76.62%,and 75.37%,respectively,whereas the tradi-tional similarity evaluation values were 98.68%,85.43%,and 85.60%,respectively.Conclusion The results perform little distinction in the total composition between FG and FD,whereas some distinction existed between FD and CP.Experimental evidence,therefore indicates that FG could be used as the alternative of MCS in clinical applications.展开更多
目的探究氯沙坦钾联合复方石韦颗粒治疗慢性肾小球肾炎的临床疗效及对患者血清炎症因子[白细胞诱素-1(LKN-1)、白细胞介素-33(IL-33)及肿瘤坏死因子-α(TNF-α)]水平的影响。方法选取2019年1月至2020年12月衡阳市中心医院收治的95例慢...目的探究氯沙坦钾联合复方石韦颗粒治疗慢性肾小球肾炎的临床疗效及对患者血清炎症因子[白细胞诱素-1(LKN-1)、白细胞介素-33(IL-33)及肿瘤坏死因子-α(TNF-α)]水平的影响。方法选取2019年1月至2020年12月衡阳市中心医院收治的95例慢性肾小球肾炎患者作为研究对象,按照随机数字表法分为观察组(n=47)与对照组(n=48)。对照组单用氯沙坦钾治疗,观察组采用氯沙坦钾联合复方石韦颗粒治疗,比较两组临床疗效、治疗前后尿常规指标[尿红细胞计数(RBC)、24 h尿蛋白定量(24 h Upro)、尿β_(2)-微球蛋白(β_(2)-MG)]和血清炎症因子水平及急性生理学及慢性健康状况评分系统Ⅱ(APACHEⅡ)、健康状况调查简表(SF-36)评分。结果观察组治疗总有效率为95.74%,明显高于对照组的72.92%,差异有统计学意义(P<0.05)。治疗后,两组RBC、24 h Upro、β_(2)-MG水平均明显低于治疗前,且观察组低于对照组,差异有统计学意义(P<0.05)。治疗后,两组血清LKN-1、IL-33及TNF-α水平均明显低于治疗前,且观察组低于对照组,差异有统计学意义(P<0.05)。治疗后,两组APACHEⅡ评分均明显低于治疗前,SF-36评分均明显高于治疗前,且观察组APACHEⅡ评分低于对照组,SF-36评分高于对照组,差异有统计学意义(P<0.05)。两组治疗过程中均未发生明显不良反应。结论氯沙坦钾联合复方石韦颗粒治疗慢性肾小球肾炎效果显著,能改善患者肾功能,降低血清LKN-1、IL-33及TNF-α水平,提高患者健康状况及生命质量。展开更多
目的:系统评价复方金钱草颗粒治疗泌尿系结石术后的有效性和安全性。方法:计算机检索中国知网、万方数据库、维普数据库、中国生物医学文献数据库、PubMed、the Cochrane Library、Embase和Wed of Science,搜集关于复方金钱草颗粒治疗...目的:系统评价复方金钱草颗粒治疗泌尿系结石术后的有效性和安全性。方法:计算机检索中国知网、万方数据库、维普数据库、中国生物医学文献数据库、PubMed、the Cochrane Library、Embase和Wed of Science,搜集关于复方金钱草颗粒治疗泌尿系结石术后的随机对照研究。检索时限为建库至2023年1月。采用RevMan 5.4软件进行Meta分析。结果:共纳入10项研究。Meta分析结果显示,对于术后未留置双J管的患者,复方金钱草颗粒组的总有效率高于空白对照组,差异有统计学意义(RR=1.18,95%CI=1.09~1.27,P<0.0001);在常规治疗基础上联合复方金钱草颗粒对泌尿系结石患者术后国际前列腺症状评分(IPSS)(MD=-2.81,95%CI=-3.25~-2.36,P<0.00001)和膀胱过度活动症评分(OABSS)(MD=-3.48,95%CI=-5.64~-1.33,P=0.002)的改善效果优于单纯使用常规治疗,差异均有统计学意义;相比于空白对照、单纯抗感染治疗,复方金钱草颗粒单药及其联合抗感染治疗可以降低术后留置双J管患者术后并发症发生率,差异有统计学意义(RR=0.29,95%CI=0.12~0.72,P=0.008);与空白对照、左氧氟沙星比较,复方金钱草颗粒能缩短术后结石排出时间,差异均有统计学意义(P<0.05);与单纯抗感染治疗相比,术后加用复方金钱草颗粒患者的术后结石排出时间更短,差异有统计学意义(P<0.01)。结论:复方金钱草颗粒能够提高泌尿系结石术后患者的治疗总有效率,改善IPSS评分和OABSS评分,缩短术后结石排出时间,减少留置双J管引起的并发症,且没有明显的不良反应。展开更多
文摘[Objectives]To establish an High Performance Liquid Chromatography(HPLC)method for simultaneous determination of four amino acids in Fufang Ejiao Buxue Granule.[Methods]The quantitative analysis was carried out with a Waters Sunfire C 18 column(4.6 mm×250 mm,5μm).A binary mobile solvent was used:mobile solvent A was acetonitrile-0.1 mol/L sodium acetate solution(adjusting pH to 6.5 with 36%acetic acid)(7∶93)and mobile solvent B was acetonitrile-H 2O(4∶1).The mobile phase was delivered at a flow rate of 1.0 mL/min with a gradient elution profile(0-13 min,100%A→93%A;13-17.9 min,93%A→88%A;17.9-29.0 min,88%A→85%A;29-39 min,85%A→66%A;39-45 min,66%A→0%A).The column temperature was at 43℃.The detection wavelength was 254 nm.[Results]The injection volume of L-hydroxyproline,glycine,alanine,and L-proline showed a good linear relationship with the chromatographic peak area in the range of 0.012 to 0.117,0.022 to 0.218,0.010 to 0.097,0.016 to 0.160μg,separately.The average recovery rate(n=6)was 96.4%,97.3%,97.1%,and 99.4%,respectively;the relative standard deviations were 1.2%,1.9%,1.7%,and 0.9%,respectively.[Conclusions]This method is simple in operation and good in reproducibility,and provides a reliable method for controlling the quality of Fufang Ejiao Buxue Granules.
基金Hunan Provincial Natural Science Foundation of China(2019JJ40220 and 2021JJ30514)Hunan Provincial Administration of Traditional Chinese Medicine(2021204and 2021073)+1 种基金Scientific Research Fund of Hunan Provincial Education Department(2021204 and 2021073)Pharmaceutical Open Fund of Domestic First-class Disciplines(Cultivation)of Hunan Province(2018YX11)。
文摘Objective To explore the transitive regularity of holistic constituents from the crude slices of the medicinal raw materials(MCS)to the formula granules(FG),fufang decoction(FD),and finally,the concentrated pills(CP)of Liuwei Dihuang Fufang(六味地黄复方,LWDHF).Methods Samples for MCS,FG,FD,and CP of LWDHF were obtained,and a fingerprint data-base was established using high-performance liquid chromatography(HPLC),by separating the samples in an XB-C18 column and analyzing the transitive regularity of components us-ing the total quantum statistical moment(TQSM),including total quantum zero moment(AUCT),total quantum first moment(MRTT),total quantum second moment(VRTT),and its similarity approach.The AUCT,MRTT,and VRTT were calculated based on the representative HPLC chromatograms of FG,FD,and CP of LWDHF.Results AUCT of FG,FD,and CP of LWDHF was 71804,46553,and 144646μV·s,respectively;MRTT was 14.43,14.54,and 18.85 min,respectively;and VRTT was 106.98,112.84,and 269.12 min2,respectively.Comparing the similarity of FG/FD,FG/CP and FD/CP of LWDHF,the TQSM similarity values were 98.66%,76.62%,and 75.37%,respectively,whereas the tradi-tional similarity evaluation values were 98.68%,85.43%,and 85.60%,respectively.Conclusion The results perform little distinction in the total composition between FG and FD,whereas some distinction existed between FD and CP.Experimental evidence,therefore indicates that FG could be used as the alternative of MCS in clinical applications.
文摘目的探究氯沙坦钾联合复方石韦颗粒治疗慢性肾小球肾炎的临床疗效及对患者血清炎症因子[白细胞诱素-1(LKN-1)、白细胞介素-33(IL-33)及肿瘤坏死因子-α(TNF-α)]水平的影响。方法选取2019年1月至2020年12月衡阳市中心医院收治的95例慢性肾小球肾炎患者作为研究对象,按照随机数字表法分为观察组(n=47)与对照组(n=48)。对照组单用氯沙坦钾治疗,观察组采用氯沙坦钾联合复方石韦颗粒治疗,比较两组临床疗效、治疗前后尿常规指标[尿红细胞计数(RBC)、24 h尿蛋白定量(24 h Upro)、尿β_(2)-微球蛋白(β_(2)-MG)]和血清炎症因子水平及急性生理学及慢性健康状况评分系统Ⅱ(APACHEⅡ)、健康状况调查简表(SF-36)评分。结果观察组治疗总有效率为95.74%,明显高于对照组的72.92%,差异有统计学意义(P<0.05)。治疗后,两组RBC、24 h Upro、β_(2)-MG水平均明显低于治疗前,且观察组低于对照组,差异有统计学意义(P<0.05)。治疗后,两组血清LKN-1、IL-33及TNF-α水平均明显低于治疗前,且观察组低于对照组,差异有统计学意义(P<0.05)。治疗后,两组APACHEⅡ评分均明显低于治疗前,SF-36评分均明显高于治疗前,且观察组APACHEⅡ评分低于对照组,SF-36评分高于对照组,差异有统计学意义(P<0.05)。两组治疗过程中均未发生明显不良反应。结论氯沙坦钾联合复方石韦颗粒治疗慢性肾小球肾炎效果显著,能改善患者肾功能,降低血清LKN-1、IL-33及TNF-α水平,提高患者健康状况及生命质量。
